PL-5283 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.044800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.348200E-01
Normal-vs-Stage2
7.845400E-01
Normal-vs-Stage3
5.251200E-01
Normal-vs-Stage4
6.614600E-01
Stage1-vs-Stage2
4.897800E-01
Stage1-vs-Stage3
1.594370E-01
Stage1-vs-Stage4
9.674200E-01
Stage2-vs-Stage3
1.911840E-01
Stage2-vs-Stage4
5.366200E-01
Stage3-vs-Stage4
3.670000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.540600E-01
Normal-vs-AfricanAmerican
8.855400E-01
Normal-vs-Asian
4.805600E-01
Caucasian-vs-AfricanAmerican
7.093200E-01
Caucasian-vs-Asian
7.828400E-02
AfricanAmerican-vs-Asian
3.621800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.107600E-01
Normal-vs-Female
5.862000E-01
Male-vs-Female
2.474400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.962800E-01
Normal-vs-Age(41-60Yrs)
2.917000E-01
Normal-vs-Age(61-80Yrs)
9.741000E-01
Normal-vs-Age(81-100Yrs)
7.238800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.679200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.797600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.475200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.183500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.445000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.477200E-01
Normal-vs-Daily Drinker
7.569800E-01
Normal-vs-Weekly Drinker
5.967400E-01
Normal-vs-Occasional Drinker
5.418000E-01
Normal-vs-Social Drinker
3.320200E-01
Non Drinker-vs-Daily Drinker
2.847400E-01
Non Drinker-vs-Weekly Drinker
1.710230E-01
Non Drinker-vs-Occasional Drinker
1.080960E-01
Non Drinker-vs-Social Drinker
1.723880E-02
Daily Drinker-vs-Weekly Drinker
6.937800E-01
Daily Drinker-vs-Occasional Drinker
5.964200E-01
Daily Drinker-vs-Social Drinker
1.699000E-01
Weekly Drinker-vs-Occasional Drinker
9.291800E-01
Weekly Drinker-vs-Social Drinker
3.697000E-01
Occasional Drinker-vs-Social Drinker
3.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.621400E-01
Normal-vs-Grade 2
8.875600E-01
Normal-vs-Grade 3
9.072600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.044800E-01
Grade 1-vs-Grade 3
5.418000E-01
Grade 1-vs-Grade 4
8.621400E-01
Grade 2-vs-Grade 3
6.076000E-01
Grade 2-vs-Grade 4
8.875600E-01
Grade 3-vs-Grade 4
9.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.047200E-01
Normal-vs-NonDiabetic
6.410800E-01
Diabetic-vs-NonDiabetic
2.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.380000E-01
Normal-vs-NoPancreatitis
7.202400E-01
Pancreatitis-vs-NoPancreatitis
5.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.573400E-01
Normal-vs-N1
7.329000E-01
N0-vs-N1
5.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.211600E-01
Normal-vs-TP53-NonMutant
9.153800E-01
TP53-Mutant-vs-TP53-NonMutant
8.018200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
